Alignment Healthcare vs Concentra Group Holdings Parent
Add, change or remove companies; up to four.
The short version
- Alignment Healthcare is the larger business, with $3.9B of revenue in fiscal 2025 against $2.2B for Concentra Group Holdings Parent, about 1.8 times as much.
- Alignment Healthcare grew revenue faster (46.1%, against 13.9%).
- Concentra Group Holdings Parent kept more of each dollar of sales as operating profit (15.4% operating margin, against 0.4%).
- Concentra Group Holdings Parent turned more of its sales into free cash flow (9.1% FCF margin, against 2.9%).
- Investors pay more for each dollar of Alignment Healthcare’s earnings: a P/E of 42.4x against 25.3x for Concentra Group Holdings Parent.
| Latest fiscal year | ALHC · FY25 | CON · FY25 |
|---|---|---|
| Size | ||
| Market cap | $1.7B | $5.0B |
| Revenue | $3.9B | $2.2B |
| Free cash flow | $113M | $197M |
| Net income | −$0.7M | $166M |
| Growth | ||
| Revenue growth | 46.1% | 13.9% |
| 5-year growth | 32.7% | — |
| Share count change | 3.8% | 12.3% |
| Profitability | ||
| Gross margin | — | — |
| Operating margin | 0.4% | 15.4% |
| Net margin | −0.0% | 7.7% |
| FCF margin | 2.9% | 9.1% |
| Return on capital | — | 14.9% |
| Return on equity | −0.5% | 49.8% |
| Balance sheet | ||
| Net debt | −$281M | $1.5B |
| Net debt / EBITDA | −6.2x | 3.7x |
| Dividends and buybacks | $0.0M | $54.5M |
| Valuation & quality | ||
| P/E | 42.4x | 25.3x |
| Piotroski F-score | 5 | 5 |
Revenue
FY19
ALHC $757M
CON —
FY20
ALHC $959M
CON —
FY21
ALHC $1.2B
CON —
FY22
ALHC $1.4B
CON $1.7B
FY23
ALHC $1.8B
CON $1.8B
FY24
ALHC $2.7B
CON $1.9B
FY25
ALHC $3.9B
CON $2.2B
ALHC
CON
Operating margin
FY19
ALHC −3.9%
CON —
FY20
ALHC −0.6%
CON —
FY21
ALHC −15.3%
CON —
FY22
ALHC −9.0%
CON 15.0%
FY23
ALHC −7.0%
CON 15.7%
FY24
ALHC −3.8%
CON 16.0%
FY25
ALHC 0.4%
CON 15.4%
ALHC
CON
Free cash flow
FY19
ALHC —
CON —
FY20
ALHC —
CON —
FY21
ALHC —
CON —
FY22
ALHC −$69.2M
CON $228M
FY23
ALHC −$95.2M
CON $169M
FY24
ALHC −$6.7M
CON $210M
FY25
ALHC $113M
CON $197M
ALHC
CON
Return on capital
FY19
ALHC —
CON —
FY20
ALHC —
CON —
FY21
ALHC —
CON —
FY22
ALHC —
CON —
FY23
ALHC —
CON —
FY24
ALHC —
CON —
FY25
ALHC —
CON 14.9%
ALHC
CON
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.